Placentex Pdrn Solution
Aug 24,2022 | iRENICE
New Placentex Pdrn Solution Injectable dermal filler ha filler injection werinkles filler
Placentex available forms, composition, doses: infoForm of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Biological principle:
First of all, PDRN is almost the same as the DNA base composition of the human body, ensuring high compatibility with the human body. As an adenylate A2A receptor agonist, it promotes the secretion of dermal fibroblasts and tissue regeneration by enhancing DNA synthesis;
Secondly, it promotes the secretion of vascular endothelial growth factor (VEGF), promotes the migration, proliferation and blood vessel formation of vascular endothelial cells;
Furthermore, the nucleotides formed by the decomposition of DNA bind to the adenosine A2A receptor, which can regulate related inflammatory and anti-inflammatory factors in both directions, and can exert a sustained anti-inflammatory effect.